GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | PARP1 | affects binding | EXP | | 6480464 | CTD | PARP1 protein binds to Zinc; PARP1 protein modified form binds to Zinc; Zinc binds to PARP1 protein | PMID:24275069 PMID:25549802 PMID:31152818 | PARP1 | increases cleavage | EXP | | 6480464 | CTD | Zinc deficiency results in increased cleavage of PARP1 protein; Zinc results in increased cleavage of PARP1 protein | PMID:16472982 PMID:16799065 PMID:23377617 PMID:28507149 | PARP1 | increases folding | EXP | | 6480464 | CTD | Zinc results in increased folding of PARP1 protein | PMID:31152818 | PARP1 | multiple interactions | EXP | | 6480464 | CTD | [Lead co-treated with Cadmium co-treated with Mercury co-treated with Copper co-treated with Zinc co-treated with Manganese co-treated with Chromium co-treated with Nickel] results in increased cleavage of PARP1 protein; Cisplatin inhibits the reaction [Zinc binds to PARP1 protein]; Dopamine promotes the reaction [Zinc deficiency results in increased cleavage of PARP1 protein]; imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) inhibits the reaction [Zinc binds to PARP1 protein]; linsidomine inhibits the reaction [PARP1 protein binds to Zinc]; Luteolin inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Copper co-treated with Zinc co-treated with Manganese co-treated with Chromium co-treated with Nickel] results in increased cleavage of PARP1 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc binds to PARP1 protein]; Organogold Compounds inhibits the reaction [Zinc binds to PARP1 protein]; RAPTA-T inhibits the reaction [Zinc binds to PARP1 protein]; sodium arsenite inhibits the reaction [PARP1 protein binds to Zinc]; sodium arsenite inhibits the reaction [Zinc binds to PARP1 protein]; Uric Acid inhibits the reaction [sodium arsenite inhibits the reaction [PARP1 protein binds to Zinc]]; Zinc affects the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein]; Zinc binds to and results in increased activity of PARP1 protein; Zinc deficiency promotes the reaction [Dopamine results in increased cleavage of PARP1 protein]; Zinc inhibits the reaction [arsenite results in decreased activity of PARP1 protein]; Zinc inhibits the reaction [monomethylarsonous acid results in decreased activity of PARP1 protein]; Zinc inhibits the reaction [sodium arsenite inhibits the reaction [Zinc binds to PARP1 protein]]; Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein] | PMID:15966574 PMID:18707137 PMID:21370912 PMID:21925530 PMID:23377617 PMID:24275069 PMID:28552776 PMID:29115570 PMID:31152818 | PARP1 | decreases expression | ISO | Parp1 (Rattus norvegicus) | 6480464 | CTD | Zinc results in decreased expression of PARP1 protein | PMID:16799065 | PARP1 | multiple interactions | ISO | Parp1 (Mus musculus) | 6480464 | CTD | PARP1 protein affects the reaction [Zinc results in decreased abundance of Adenosine Triphosphate]; PARP1 protein affects the reaction [Zinc results in decreased uptake of Excitatory Amino Acid Agents]; Zinc inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein] | PMID:17728843 PMID:26443841 | PARP1 | multiple interactions | ISO | Parp1 (Rattus norvegicus) | 6480464 | CTD | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in decreased expression of PARP1 protein]; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Zinc deficiency] results in increased cleavage of PARP1 protein; Metipranolol inhibits the reaction [Zinc results in decreased expression of PARP1 protein] | PMID:16799065 PMID:31542844 | |
Go Back to source page | Continue to Ontology report |